ANXA1 and infectious disease: The compelling evidence for the role of AnxA1 in the resolution of inflammation (see above; for review see ref. 132) has triggered the use of the AnxA1 protein and its N-terminal peptides (the FPR-binding epitope89) in the treatment of inflammatory and infectious disorders in animal models.